Get alerts of updates about «Determinants of hypertension following pregnancy»
You have subscribed to alerts about:
- Determinants of hypertension following pregnancy
Project
Determinants of hypertension following pregnancy - project description
Published Updated
The project will contribute to our understanding of the life-course epidemiology of cardiovascular disease in women and guide in the development of relevant intervention strategies.
Summary
Cardiovascular diseases (CVD) are the leading causes of death in women and hypertension is one of the most important modifiable risk factors for CVD. The project evaluates lifestyle characteristics and hypertension disorders of pregnancy as determinants of chronic hypertension. The project utilizes the Norwegian Mother and Child Cohort (MoBa) with linkages to the Norwegian Medical Birth Registry for ascertainment of pregnancy-related complications and outcomes. Further, linkages to the National Prescription Database provide information on the use of anti-hypertensive medications following pregnancy. The project will contribute to our understanding of the life-course epidemiology of cardiovascular disease in women and guide in the development of relevant intervention strategies. Further, with Regional Ethics Committee approvals in the fall of 2017, the project was expanded to include diabetes mellitus as an outcome utilizing the same data material.
See the full project description at Cristin for more information about results, researchers, contact information etc.
Project participants
Project leader
Anne Lise Brantsæter, Norwegian Institute of Public Health
Project participants
Grace Margrethe Egeland, Avdeling for helseregisterforskning og -utvikling, Norwegian Institute of Public Health
Kristin Øksendal Børresen, Department of Clinical Medicine, University of Bergen
Hanne Rosendahl-Riise, Department of Clinical Medicine, University of Bergen
Jannike Øyen, Seafood and nutrition, Institute of Marine Research
Mari Bergflødt Sørensen, Department of Clinical Medicine, University of Bergen
James Hebert, USA
Jutta Dierkes, Department of Clinical Medicine, University of Bergen
Svetlana Ondrasova Skurtveit, Mental Disorders, Norwegian Institute of Public Health
Anne Kjersti Nesje Daltveit, Avdeling for helseregisterforskning og -utvikling, Norwegian Institute of Public Health
Alice Margareta Haugen, Infection Control, Norwegian Institute of Public Health
Teresa Risan Haugsgjerd, Department of Clinical Science, University of Bergen